Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Supply Chain & Pharmacy Partnerships One of the most significant impacts would occur at the pharmacy level
IJMS 17, 2146
Cardiovasc Diagn Ther
The most notable is its capacity for substantial weight reduction, which may in turn confer downstream benefits including: Improved glycaemic control in individuals with type 2 diabetes Reduced cardiovascular risk factors such as hypertension and dyslipidaemia Potential improvement in hepatic steatosis , given the glucagon receptor component's proposed role in hepatic fat metabolism Possible improvements in physical function and quality of life associated with significant weight loss though these outcomes have not yet been formally established for retatrutide and require confirmation in Phase 3 trials As with all medicines in this class, retatrutide carries a recognised side effect profile
It does not differentiate between someone targeting 10% body weight loss and someone targeting 25%
